Shattuck Labs Inc header image

Shattuck Labs Inc

STTK

Equity

ISIN null / Valor 57260669

UTP NYSE Arca (2026-02-23)
USD 4.23+5.49%

Shattuck Labs Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Shattuck Labs Inc. is a biotechnology firm focused on the development of innovative immunotherapy treatments. The company has built a significant portfolio, comprising over 400 bi-functional fusion proteins. These proteins are designed to target a range of clinically validated and emerging pathways, enabling Shattuck Labs to develop therapies that aim to be both best-in-class and first-in-class. This approach suggests a strategic focus on leveraging cutting-edge science to address unmet medical needs in the field of immunotherapy, positioning the company at the forefront of advancements in treatment methodologies. Through its proprietary technologies and extensive portfolio, Shattuck Labs seeks to make a meaningful impact on patient care in the oncology and autoimmune disease spaces.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

209%1Y
-6.83%3Y
-88.9%5Y

Performance

133%1Y
125%3Y
108%5Y

Volatility

Market cap

268 M

Market cap (USD)

Daily traded volume (Shares)

703,557

Daily traded volume (Shares)

1 day high/low

1.3 / 1.17

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.43%CHF 18.60
EssilorLuxottica SA
EssilorLuxottica SA EssilorLuxottica SA Valor: 497537
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.92%EUR 236.00
bioMerieux SA
bioMerieux SA bioMerieux SA Valor: 38147803
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.58%EUR 94.70
Siemens Healthineers AG
Siemens Healthineers AG Siemens Healthineers AG Valor: 40652181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.89%EUR 41.55
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.65%EUR 51.72
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%EUR 41.39
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.72%USD 2.77
Vita 34 AG
Vita 34 AG Vita 34 AG Valor: 2333201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.89%EUR 5.20
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.06%EUR 0.95
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.74%USD 21.19